Baxion
Screening
Tags
Alerts
Theme
Biodexa Pharmaceuticals PLC
BDRX
·
NASDAQ
·
$3.24
Share Price as of 11/2
·
$543,533
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
20-F
Annual report (foreign)
03/27/26
20-F
Annual report (foreign)
04/11/25
20-F
Annual report (foreign)
04/19/24
20-F/A
Annual report (foreign, amended)
05/05/23
20-F
Annual report (foreign)
04/28/23
Disclosures
Filter
6-K
Foreign issuer report
10/14/26
6-K
Foreign issuer report
10/08/26
6-K
Foreign issuer report
09/15/26
6-K
Foreign issuer report
09/11/26
6-K
Foreign issuer report
07/29/26
Prospectuses and Registrations
Filter
424B3
Prospectus
10/14/26
424B3
Prospectus
10/14/26
424B3
Prospectus
10/14/26
424B3
Prospectus
10/14/26
424B3
Prospectus
10/14/26
Proxies
Filter
No matching filings.
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
05/15/26
Form 3
Initial insider ownership
03/20/26
Form 3
Initial insider ownership
03/18/26
Form 3
Initial insider ownership
03/18/26
Other
Filter
EFFECT
Request for effectiveness
09/30/26
EFFECT
Request for effectiveness
08/03/26
EFFECT
Request for effectiveness
03/30/26
EFFECT
Request for effectiveness
03/30/26
EFFECT
Request for effectiveness
03/30/26
Latest Filings
Filter
6-K
Foreign issuer report
10/14/26
424B3
Prospectus
10/14/26
424B3
Prospectus
10/14/26
424B3
Prospectus
10/14/26
424B3
Prospectus
10/14/26
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
05/15/26
Form 3
Initial insider ownership
03/20/26
Form 3
Initial insider ownership
03/18/26
Form 3
Initial insider ownership
03/18/26